teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi, sérhæfður ónæmisbælandi - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
sitagliptin sandoz filmuhúðuð tafla 100 mg
sandoz a/s* - sitagliptinum hýdróklóríð - filmuhúðuð tafla - 100 mg
sitagliptin krka filmuhúðuð tafla 100 mg
krka d.d. novo mesto* - sitagliptinum inn - filmuhúðuð tafla - 100 mg
lopid hart hylki 300 mg
pfizer aps - gemfibrozilum inn - hart hylki - 300 mg
lopid filmuhúðuð tafla 600 mg
pfizer aps - gemfibrozilum inn - filmuhúðuð tafla - 600 mg
sitagliptin krka filmuhúðuð tafla 50 mg
krka d.d. novo mesto* - sitagliptinum inn - filmuhúðuð tafla - 50 mg
sitagliptin zentiva filmuhúðuð tafla 50 mg
zentiva k.s.* - sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50 mg
sitagliptin krka filmuhúðuð tafla 25 mg
krka d.d. novo mesto* - sitagliptinum inn - filmuhúðuð tafla - 25 mg
sitagliptin/metformin medical valley filmuhúðuð tafla 50mg/1000 mg
medical valley invest ab - metforminum hýdróklóríð; sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50mg/1000 mg